Millions of Americans who suffer every day from gastroesophageal reflux disease (GERD) can now be helped with the new incisionless procedure, EsophyX™. Dr. Paul Cirangle is the first and only physician in San Francicso to offer this non-invasive alternative to pills.
San Francisco, CA (PRWEB) November 14, 2008 -- EsophyX™ is the first device for incisionless reconstructive surgical treatment of gastroesophageal reflux disease (GERD) and is based on the principals of surgical repair of the gastroesophageal junction.
EsophyX is now available from Paul Cirangle, MD, FACS, of Laparoscopic Associates of San Francisco. Dr. Cirangle, a leader in the treatment of GERD and a pioneer in bariatric surgery, is the first specialist in San Francisco to be trained on the EsophyX™ procedure. "EsophyX™ can significantly improve quality of life for our patients," said Dr. Cirangle. "Many reflux patients are unable to consume carbonated beverages, caffeine, rich foods or fruit without triggering reflux. They also sleep sitting up to reduce nighttime reflux. After the EsophyX procedure, clinical trials show that most patients can eat and drink foods they avoided for many years. Reflux no longer impacts their life like it previously did. They can finally get back to living."
EsophyX and the Transoral Incisionless Fundoplication™ (TIF) procedure also offer a number of other benefits due to their minimal invasiveness. EsophyX represents the third generation of surgery. The transition from open surgery to laparoscopy has been regarded as the major advance in surgery in the last two decades. Laparoscopy reduced the skin incisions typical of open surgery to only from three-to-five port holes. EsophyX, however, is a giant leap forward and avoids incisions altogether. EsophyX-TIF never requires internal dissections. Because of this reduced invasiveness, EsophyX lowers the hurdle for receiving an anatomical restoration of the antireflux barrier and allows earlier intervention.
With millions of Americans diagnosed with GERD and not fully satisfied with their treatment options, EsophyX offers an excellent alternative. "Recent studies of EsophyX have shown that the procedure can reduce patients' dependency on medications with 80% of patients remaining symptom free after two years and experiencing a dramatic improvement in their quality of life," said Dr. Cirangle. "We are very excited to be able to offer our patients the same incredible benefits with minimal risk."
In addition to the EsophyX procedure, Laparoscopic Associates of San Francisco and The Surgical Weight Loss Center of Hawaii also offers four weight loss surgeries; the adjustable gastric band (LAP-BAND® and REALIZE™), Roux-en-Y gastric bypass, vertical sleeve gastrectomy , and the duodenal switch. These procedures are all done laparoscopically, with very little downtime.
Dr. Cirangle advises that anyone interested in the EsophyX™ or weight-loss surgery options, such as the vertical sleeve gastrectomy, should research the options beforehand and should only consult a board-certified surgeon with proven experience and expertise in the procedure preferred. For more information, please call 1-866-WLS-DOCS or visit www.lapsf.com
-Please contact Nicole Kimbrough at (415) 561-1310 email@example.com
-Please link our practice, Laparoscopic Associates of San Francisco, to our website: www.lapsf.com
-Please link this to "vertical sleeve gastrectomy" in the second to last paragraph: http://www.lapsf.com/vertical-gastrectomy-weight-loss-surgery.php
-Please link The Surgical Weight Loss Center of Hawaii to www.hawaiiweightloss.com
Read the full story at http://www.prweb.com/releases/2008/11/prweb1615424.htm
Copyright©2008 Vocus, Inc.
All rights reserved